Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 123 of the 124 references it cites were found in a registry or an index.

The Role of GLP-1 in Neuronal Activity and Neurodegeneration

Hölscher, Christian · 2010 · Vitamins & Hormones

Abstract

Type 2 diabetes has been identified as a risk factor for Alzheimer's disease (AD). The underlying mechanism behind this unexpected link is most likely linked to the observed desensitization of insulin receptors in the brain. Insulin acts as a growth factor in the brain and supports neuronal repair, dendritic sprouting, and differentiation. Several drugs have been developed to treat type 2 diabetes which re-synthesize insulin receptors and may be of use to prevent neurodegenerative developments in AD. The incretin glucagon-like peptide-1 (GLP-1) is a hormone that facilitates insulin release under high blood sugar conditions. Interestingly, GLP-1 also has very similar growth factor like properties as insulin, and has been shown to protect neurons from toxic effects. In preclinical studies, GLP-1 and longer lasting analogues reduce apoptosis, protect neurons from oxidative stress, induce neurite outgrowth, protect synaptic plasticity and memory formation from the detrimental effects of β-amyloid, and reduce plaque formation and the inflammation response in the brains of mouse models of AD. An advantage of GLP-1 is that it does not affect blood sugar levels in nondiabetic people. Furthermore, recent research has shown that some GLP-1 analogues can cross the blood-brain barrier, including two that are on the market as a treatment for type 2 diabetes. Therefore, GLP-1 analogues show great promise as a novel treatment for AD or other neurodegenerative conditions.

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-12-381517-0.00013-8

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 124 references

Cited by

See all 74

Metadata

Authors
Hölscher, C.
Affiliations
University of Ulster (GB)
Corresponding author
Hölscher, Christian
Venue
Vitamins & Hormones
Publisher
Elsevier
Published
2010
Volume
84
Pages
331-354
ISSN
0083-6729 (ISSN-L)
OpenAlex
W1601982370
Cited by
74
References
124
Citations by year
2026: 2 · 2025: 7 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 7 · 2017: 7 · 2016: 3 · 2015: 4 · 2014: 3 · 2013: 6 · 2012: 11
FWCI
22.52
Type
book chapter
Language
en
Open access
closed
Locations
  • Vitamins and hormones (publishedVersion)
  • PubMed (publishedVersion)
  • Lancaster EPrints (Lancaster University) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
glucagon-like peptide-1, GLP-1 analogues, Alzheimer's disease, neurodegeneration, type 2 diabetes, neuroprotection, amyloid-beta, neuroinflammation, blood-brain barrier, synaptic plasticity, memory formation, oxidative stress, apoptosis, neurite outgrowth
MeSH terms
Alzheimer Disease, Animals, Blood-Brain Barrier, Diabetes Mellitus, Type 2, Humans, Nerve Degeneration, Receptor, Insulin, Glucagon-Like Peptide 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of GLP-1 in Neuronal Activity and Neurodegeneration. https://app.cochat.ai/papers/10.1016/b978-0-12-381517-0.00013-8
The paper
Hölscher, C. (2010). The Role of GLP-1 in Neuronal Activity and Neurodegeneration. Vitamins & Hormones. https://doi.org/10.1016/b978-0-12-381517-0.00013-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.